PHC Holdings
- Company typePublic
- Founded2014
- HeadquartersTokyo, Japan
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
PHC Holdings firmographics
Firmographics- Name
- PHC Holdings
- Legal name
- PHC Holdings Corporation
- Website
- https://www.phchd.com/jp
- Company type
- Public
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
PHC Holdings industry classification
Industry- Product category
- Medical Devices and Healthcare Technology
- NAICS
- Software Publishers (513210), Management of Companies and Enterprises (551)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)
- akta.pro secondary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where PHC Holdings is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices12 records
Markets served
PHC Holdings business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Life Sciences and Biomedical Equipment Sales: Sale of research and medical support equipment including ultra-low temperature freezers, CO2 incubators, pharmaceutical refrigerators, and cell culture systems. Products sold directly and through distribution channels globally.
- Diabetes Management Products: Blood glucose monitoring systems (BGM) and digital diabetes management solutions sold through Ascensia Diabetes Care subsidiary in over 90 countries, serving approximately 10 million users worldwide
- Diagnostic Reagents and Instruments: In vitro diagnostic reagents measuring blood components including coagulation and fibrinolysis, immunochromatography reagents for influenza and COVID-19, and compact immunoassay analyzers like PATHFAST
- Healthcare IT Solutions: Electronic medical record systems (Medicom), electronic medication history systems (PharnesX), and health guidance systems provided through Wemex subsidiary for clinics, hospitals, and pharmacies in Japan
- Clinical Testing Services: Laboratory analysis services in clinical testing, cancer diagnostics, genetic testing, and sports anti-doping testing provided through LSI Medience
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | MDF-DU702VX TwinGuard Ultra Low Freezer - Price Upon Inquiry |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
PHC Holdings product offering
Product offeringCore offering
PHC Holdings Corporation is a diversified healthcare technology group that develops, manufactures, and sells medical devices and equipment across three business domains: Diabetes Management (blood glucose monitoring systems and digital diabetes solutions via Ascensia), Life Sciences and Diagnostics (ultra-low temperature freezers, CO2 incubators, pharmaceutical refrigerators, cell therapy products, and in vitro diagnostic reagents via PHC Corporation, LSI Medience, and Epredia), and Healthcare Solutions (electronic medical records, medication history systems, and contract research services via Wemex and Mediford). Its products serve patients, healthcare professionals, and researchers in more than 125 countries.
Product overview
PHC Holdings Corporation operates as a diversified healthcare technology group organized across three business domains: Diabetes Management, Life Sciences and Diagnostics, and Healthcare Solutions. The product portfolio includes the Ascensia brand of blood glucose monitoring systems and digital diabetes management apps; PHCbi-branded life sciences equipment including ultra-low temperature freezers (TwinGuard, VIP ECO, VIP Series), CO2 incubators with H2O2 decontamination, pharmaceutical refrigerators, and cell therapy products (LiCellMo metabolic analyzer, LiCellGrow expansion system under development); LSI Medience clinical testing and diagnostic reagents including the PATHFAST immunoassay analyzer; Wemex's Medicom electronic medical record systems, Medicom-HRf Hybrid Cloud, and PharnesX medication history systems for healthcare facilities; Epredia anatomical pathology and digital pathology solutions including whole slide imaging scanners; and Mediford contract research services. The company serves patients, healthcare professionals, and researchers in over 125 countries through its group subsidiaries.
Differentiator
Problem solved
Functional benefit
Brands
- Cell-IQ: CO2 Incubator series featuring active hybrid humidification technology for life science research
- TwinGuard
- LiCellGrow
- LiCellMo
- E1000 Dx
- CONTOUR
- PATHFAST
- Medicom
Products and services
- PHCbi Ultra-Low Temperature Freezers (VIP and TwinGuard series) CFC-free ultra-low temperature freezers with proprietary TwinGuard dual cooling system and VIP PLUS vacuum insulation for sample and specimen storage. ENERGY STAR certified with industry-leading energy-saving performance; supports hospital labs, biorepositories, and pharmaceutical storage.
- PHCbi CO2 Incubators (Cell-IQ series) CO2 incubators with active hybrid humidification technology, antimicrobial copper-alloy stainless steel interiors, UV-LED sterilization, and H2O2 decontamination for cell culture applications in research and biopharmaceutical laboratories.
- PHCbi Pharmaceutical Refrigerators (MPR Series) Pharmaceutical refrigerators for vaccine and critical medication storage, built in compliance with CDC pharmacy guidelines; models range from 158 to 1364 liters with natural refrigerant options.
- LiCellMo Live Cell Metabolic Analyzer Live cell metabolic analyzer measuring cellular metabolic changes continuously in real time using proprietary high-precision in-line sensors while maintaining sterility. Supports cancer research, stem cell therapies, and process development.
- LiCellGrow Cell Expansion System
Quantifiable outcome
- Humidity recovery speeds approximately twice as fast as previous models
- +3 more outcomes
Companies that use PHC Holdings
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles4 records
PHC Holdings technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
PHC Holdings partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered major, minor and core.
- Senseonics HoldingsmajorPartnership for Eversense Continuous Glucose Monitoring (CGM) products. PHC transferred commercial activities for the CGM business to Senseonics, with Ascensia previously distributing the products. The transition was completed in January 2026, with Senseonics assuming full commercial control of Eversense CGM platforms.
- BayermajorCGM business partnership involving transfer of commercial activities to Senseonics and Bayer. The Eversense 365 CGM system was previously distributed through this partnership arrangement.
- Centre for Commercialization of Regenerative Medicine (CCRM)minorPHC Group collaborated with CCRM to host an online roundtable discussion on the potential, challenges, and future outlook of CAR-T therapy in cancer treatment, exploring cell and gene therapy applications.
- JCR PharmaceuticalscoreOngoing collaboration for medication management solutions including GROWJECTOR automated injection devices and Melon Nikki medication management app for pediatric patients undergoing growth hormone therapy.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
PHC Holdings competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: Global life sciences tools leader from which PHC acquired the Anatomical Pathology business (Epredia) in 2019. Overlaps in laboratory equipment, diagnostics, and pathology — the most direct comparable given the shared history and product categories.
- Abbott Laboratories: Diversified medical device and diagnostics company with a dominant diabetes care franchise (FreeStyle Libre CGM, BGM). Comparable to PHC's Ascensia diabetes management business and overall diversified medical device portfolio.
- Roche Diabetes Care: Major diabetes management competitor (Accu-Chek) with extensive BGM/CGM offerings and integrated diagnostic solutions. Closely comparable to PHC's Ascensia division in target market and product overlap.
- Danaher Corporation: Life sciences and diagnostics conglomerate operating Beckman Coulter, Cepheid, Leica Biosystems (pathology), and more. Comparable in diversified life sciences tools, diagnostics, and pathology exposure.
- Becton Dickinson (BD): Major medical device and life sciences research tools manufacturer. Comparable in clinical laboratory equipment, diagnostic systems, and biomedical research instruments — overlapping with PHC Corporation's equipment portfolio.
- Agilent Technologies: Life sciences tools and diagnostics company providing analytical instruments and lab equipment. Comparable to PHC's biomedical division products (incubators, freezers) serving research and clinical laboratories.
Direct peers
- Eppendorf AG: German life sciences equipment manufacturer specializing in CO2 incubators, ULT freezers, bioreactors, and cell handling consumables. Direct competitor to PHCbi in the same product categories and customer base of research/biotech labs.
- Dexcom: Continuous glucose monitoring market leader and beneficiary of PHC's CGM exit to Senseonics/Bayer. Comparable as a competitor in diabetes monitoring that PHC ceded ground to in the CGM category.
- Sartorius AG: German bioprocessing and laboratory equipment manufacturer providing bioreactors and cell culture tools. Comparable to PHC's LiCellGrow/LiCellMo cell expansion and metabolic monitoring systems targeting CGT manufacturing.
Regional players
- Hamamatsu Photonics: Japanese technology company with diagnostics and digital pathology imaging solutions. Regional comparable to Epredia's whole-slide imaging scanners and PHC's broader biomedical device portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
PHC Holdings social profiles
Digital presencePHC Holdings compliance and trust
Trust signalCompliance2 records
PHC Holdings financial estimates
Financial estimateRevenue estimate
Valuation estimate
PHC Holdings leadership team
Management profileNumber of profiles
Profiles10 records
PHC Holdings subsidiaries and ownership
Company hierarchySubsidiaries9 records
PHC Holdings funding detail
Funding detailFunding overview
Funding rounds3 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PHC Holdings M&A and investment
M&A and investmentM&A3 records
Investments7 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PHC Holdings
What does PHC Holdings do?
PHC Holdings Corporation is a diversified healthcare technology group that develops, manufactures, and sells medical devices and equipment across three business domains: Diabetes Management (blood glucose monitoring systems and digital diabetes solutions via Ascensia), Life Sciences and Diagnostics (ultra-low temperature freezers, CO2 incubators, pharmaceutical refrigerators, cell therapy products, and in vitro diagnostic reagents via PHC Corporation, LSI Medience, and Epredia), and Healthcare Solutions (electronic medical records, medication history systems, and contract research services via Wemex and Mediford). Its products serve patients, healthcare professionals, and researchers in more than 125 countries.
Is PHC Holdings a public or private company?
PHC Holdings is a public company. It is classified as public and is currently operating.
When was PHC Holdings founded?
PHC Holdings was founded in 2014. It employs 5,001 to 10,000 people.
Where is PHC Holdings based?
PHC Holdings is headquartered in Tokyo, Japan, in the Asia region.
How does PHC Holdings make money?
Five revenue lines are on record. Life Sciences and Biomedical Equipment Sales are the primary driver. The others are diabetes Management Products, diagnostic Reagents and Instruments, healthcare IT Solutions and clinical Testing Services.
Who are PHC Holdings's main competitors?
Broad incumbents on record are Thermo Fisher Scientific, Abbott Laboratories, Roche Diabetes Care, Danaher Corporation, Becton Dickinson (BD) and Agilent Technologies. Direct peers are Eppendorf AG, Dexcom and Sartorius AG. Hamamatsu Photonics is listed as a regional player.
Does PHC Holdings have an API?
No public API is recorded for PHC Holdings.
What industry is PHC Holdings in?
PHC Holdings's product category is Medical Devices and Healthcare Technology. Its primary akta.pro industry code is CRADAMAK, Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 513210 and its SIC code is 3841.